Spina Bifida and primary prevention by unknown
MEETING ABSTRACT Open Access
Spina Bifida and primary prevention
Pierre Mertens
From 6th European Conference on Rare Diseases and Orphan Products
Brussels, Belgium. 23-25 May 2012
Spina Bifida is a neural tube defect (NTD), which occurs
within the first 25 days of pregnancy and affects around 1
in 1000 pregnancies in Europe. It cannot be cured,
although improved medical interventions mean that many
people with Spina Bifida live into old age and have a good
quality of life. However lifelong follow-up is required. IF is
an umbrella organisation of national organisations of per-
sons with Spina Bifida and focuses on primary prevention,
access to health and the right to life. Around 70% of Spina
Bifida can be prevented by a daily intake of Folic Acid two
months prior to conception and two after. With Folic
Acid the same child is born without Spina Bifida. Access
to life-saving treatment of new-borns with Spina Bifida is
in discussion. IF strives for the right of treatment of all
new-borns with Spina Bifida. Spina Bifida became a rare
disease because of prenatal detection and terminations of
pregnancies and not because of primary prevention.
Several hospitals closed their coordinated care units for
Spina Bifida. Research decreased and Spina Bifida is
perceived by many professionals as a solved problem.
Prevention of most of the birth defects starts before con-
ception. That’s why IF co-organised in October 2010 a
European Preconception Care conference in Brussels.
When a couple plans their pregnancy they should take all
measures to prevent possible problems: not drinking alco-
hol, not smoking, not taking drugs and taking Folic Acid.
IF advocates for fortification of staple food with Folic Acid
and set up a European awareness campaign. Most women
do not know about the risk of having a baby affected by an
NTDs. This is even truer among women of lower socio-
economic status where the incidence is higher. IF pro-
duced two reports on Prevention of NTD’s in Europe and
organised a hearing in the European Parliament. To
improve peri-conceptional folate levels women of child-
bearing age can only be reached by a combination of
counselling, intake of Folic Acid, fortified staple food and
further investment in monitoring and research. Persons
with Spina Bifida make the need for prevention visible and
IF believes that it should be integrated in National Plans
for rare diseases. In Belgium we had a first success. A cru-
cial orphan drug in the care for the neurogenic bladder is
taken for approval.
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